Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354068
Status:
COMPLETED
Last Update Posted:
2013-03-28
First Post:
2006-07-19
Brief Title:
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Sponsor:
Duke University
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00004364
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Duke University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |